| Literature DB >> 27560160 |
Patrick C Y Woo1,2,3,4, Susanna K P Lau1,2,3,4, Candy C Y Lau1, Edward T K Tung1, Ken T K Chong1, Fengjuan Yang1, Hongmin Zhang5, Raymond K C Lo1, Jian-Pao Cai1, Rex K H Au-Yeung6, Wing-Fung Ng7, Herman Tse1,2,3,4, Samson S Y Wong1,2,3,4, Simin Xu1, Wai Hei Lam5, Man-Kit Tse1, Kong Hung Sze1,2,3,4, Richard Y Kao1,2,3,4, Neil E Reiner8, Quan Hao5, Kwok-Yung Yuen1,2,3,4.
Abstract
BACKGROUND: Talaromyces marneffei is an opportunistic dimorphic fungus prevalent in Southeast Asia. We previously demonstrated that Mp1p is an immunogenic surface and secretory mannoprotein of T. marneffei. Since Mp1p is a surface protein that can generate protective immunity, we hypothesized that Mp1p and/or its homologs are virulence factors. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2016 PMID: 27560160 PMCID: PMC4999278 DOI: 10.1371/journal.pntd.0004907
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fungal strains used in this study
| Strains | Abbreviation | Characteristics | Relative gene expression level (%) | Source or reference |
|---|---|---|---|---|
| PM1 | Human strain isolated from an HIV-negative patient | [ | ||
| shRNA | PM1 derivative with | 45.3±11.4 | This study | |
| shRNA | PM1 derivative with | 4.7±3.6 | This study | |
| shRNA | PM1 derivative with | 21.6±5.6 | This study | |
| shRNA | PM1 derivative with | 32.7±6.9 | This study | |
| shRNA | PM1 derivative with | 57.6±2.8 | This study | |
| shRNA | PM1 derivative with | 8.9±5.5 | This study | |
| shRNA | PM1 derivative with | 4.7±0.9 | This study | |
| shRNA | PM1 derivative with | 23.3±9.5 | This study | |
| shRNA | PM1 derivative with | 48.4±1.7 | This study | |
| shRNA | PM1 derivative with | 19.3±5.2 | This study | |
| shRNA | PM1 derivative with | 22.6±7.9 | This study | |
| shRNA | PM1 derivative with | 34.1±9.0 | This study | |
| shRNA | PM1 derivative with | 23.9±12.7 | This study | |
| shRNA | PM1 derivative with | 57±8.3 | This study | |
| △ | PM1 derivative with | 45.3±11.4 | This study | |
| △ | This study | |||
| GS115 | Purchased from Invitrogen | |||
| GS115- | GS115 derivative with | This study | ||
Characteristics of Mp1p homologs in T. marneffei.
| Mp1p homolog | pI | Size (aa) | Molecular mass (kDa) | Intron | Subcellular localization | Lipid binding domain (aa) | N-glycosylation site | ST rich region | Signal peptide | GPI-anchor |
|---|---|---|---|---|---|---|---|---|---|---|
| Mp1p | 5.38 | 462 | 47.8 | 0 | Extracellular | 151 | 1 | 354–447 | Yes | Yes |
| MpLp1 | 4.73 | 324 | 31.3 | 1 | Extracellular | 148 | 1 | 193–299 | Yes | Yes |
| MpLp2 | 4.79 | 206 | 22.5 | 0 | Extracellular | 152 | 0 | 188–203 | Yes | No |
| MpLp3 | 5.16 | 210 | 23.4 | 0 | Extracellular | 168 | 2 | 187–208 | Yes | Yes |
| MpLp4 | 5.33 | 205 | 19.6 | 0 | Cytoplasmic | 151 | 0 | No | No | No |
| MpLp5 | 5.94 | 176 | 19.4 | 0 | Extracellular | 147 | 0 | No | Yes | No |
| MpLp6 | 6.51 | 220 | 24.1 | 0 | Extracellular | 157 | 1 | 44–63; 183–218 | Yes | No |
| MpLp7 | 8.46 | 303 | 33.9 | 1 | Nuclear | 159 | 1 | 68–118 | No | No |
| MpLp8 | 8.71 | 186 | 20.7 | 0 | Extracellular | 147 | 1 | No | Yes | No |
| MpLp9 | 8.89 | 176 | 19.6 | 0 | Extracellular | 147 | 0 | No | Yes | No |
| MpLp10 | 8.93 | 200 | 22.3 | 1 | Extracellular | 148 | 1 | No | Yes | No |
| MpLp11 | 8.98 | 224 | 24.1 | 0 | Extracellular | 155 | 1 | 182–222 | Yes | No |
| MpLp12 | 9.32 | 201 | 22.2 | 0 | Extracellular | 128 | 0 | No | Yes | No |
| MpLp13 | 5.57 | 218 | 23.3 | 0 | Extracellular | 153 | 0 | No | Yes | No |
Fig 1Predicted domains of Mp1p homologs in T. marneffei.
Fig 2Phylogenetic analysis of the putative LBD of Mp1p homologs in T. marneffei and orthologs in other fungi.
Homologs of Mp1p in T. marneffei are shown in bold. The tree was constructed by maximum likelihood method with bootstrap values calculated from 1,000 trees and rooted on midpoint. The scale bar indicates the branch lengths that correspond to 0.5 substitutions per site as indicated. Names and accession numbers are given as cited in the GenBank database.
Fig 3Mp1p is a virulence factor of T. marneffei.
(A) Survival curves of Balb/c mice challenged with T. marneffei PM1, MP1 knockout mutant, MP1 complemented mutant and knockdown mutants (***P<0.0001). (B) Mean fungal burden in spleen, kidney, liver and lung of mice challenged with T. marneffei PM1, MP1 knockout mutant, MP1 complemented mutant and MP1 knockdown mutant at day 12 post-challenge (***P<0.001, **P<0.01, *P<0.05). Error bars represent standard deviations. (C) Histopathological examination of PAS stained internal organs of mice at day 12 post-challenge. T. marneffei yeast cells are shown in black arrows and tissue necrosis in blue arrows.
Fig 4Mp1p enhances T. marneffei survival in macrophages.
Intracellular survival of T. marneffei PM1, MP1 knockout mutant, MP1 complemented mutant and MP1 knockdown mutant in murine macrophages at 2, 8, 16, 24 and 48 hours post-inoculation (**P<0.01). Error bars represent standard deviations.
Fig 5Mp1p improves survival of Pichia pastoris in mice.
Fungal burden in spleens, livers, kidneys, and lungs of mice challenged with P. pastoris GS115 and GS115-MP1 at 24 hours post-challenge (*P<0.05, ***P<0.001). Error bars represent standard deviations.